CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate

Ziwei Wei1, Cong Zhang2, Yufeng Song1

  • 1Department of Urology, Jinshan Hospital, Fudan University, 201508, Shanghai, China.

Cancer Letters
|February 29, 2024
PubMed

Insights

Circular RNA circUBE3A(2,3,4,5) suppresses prostate cancer metastasis by regulating AUF1, MTHFD2, and vimentin. This finding offers a promising new target for preventing cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic progression is a major cause of mortality in prostate cancer (PCa).
  • Circular RNAs (circRNAs) are implicated in cancer, but their role in PCa metastasis is not fully understood.

Purpose of the Study:

  • To investigate the role of circUBE3A(2,3,4,5) in prostate cancer metastasis.
  • To elucidate the underlying molecular mechanisms.

Main Methods:

  • Identification and characterization of circUBE3A(2,3,4,5) in PCa tissues.
  • In vitro and in vivo experiments to assess the functional role of circUBE3A(2,3,4,5).
  • Mechanistic studies involving AUF1, MTHFD2, and vimentin interactions.

Main Results:

  • circUBE3A(2,3,4,5) was downregulated in PCa and correlated with poor prognostic factors.
  • Overexpression of circUBE3A(2,3,4,5) inhibited PCa cell migration, invasion, metastasis, and proliferation.
  • circUBE3A(2,3,4,5) binds AUF1, promoting its nuclear translocation, reducing cytoplasmic AUF1, destabilizing MTHFD2 mRNA, and decreasing MTHFD2 protein levels, which inhibits vimentin expression and epithelial-mesenchymal transition.

Conclusions:

  • circUBE3A(2,3,4,5) acts as a suppressor of PCa metastasis.
  • The mechanism involves AUF1 nuclear translocation, MTHFD2 downregulation, and subsequent inhibition of vimentin.
  • circUBE3A(2,3,4,5) is a promising therapeutic target for preventing prostate cancer metastasis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K